Large-scale testing (Phase 3)Active Not RecruitingNCT04908202
What this trial is testing
Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
Who this might be right for
Psoriatic Arthritis
Bristol-Myers Squibb 670